Jove
Visualize
Contact Us

Related Experiment Videos

Trousseau's syndrome.

E M Woerner1, R L Rowe

  • 1University of Louisville School of Medicine, Kentucky.

American Family Physician
|September 1, 1988
PubMed
Summary
This summary is machine-generated.

Trousseau's syndrome, a cancer-associated coagulopathy, presents with varied symptoms and often hidden cancers. Heparin is the preferred treatment, while warfarin shows no benefit for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low risk management intervention: Limited impact of remedial tillage on net ecosystem carbon balance at a commercial Miscanthus plantation.

Global change biology. Bioenergy·2024
Same author

Laser pointers and the human eye: a clinicopathologic study.

Archives of ophthalmology (Chicago, Ill. : 1960)·2000
Same author

Cholesterol screening in a black inner-city pediatric population.

Southern medical journal·1991
Same author

Marfan syndrome. What you need to know.

Postgraduate medicine·1990
Same author

Experimental bacteremia and hepatic nutrient blood flow.

Circulatory shock·1986
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Hematology
  • Internal Medicine

Background:

  • Trousseau's syndrome is a rare but serious manifestation of malignancy.
  • It involves abnormal blood clotting linked to an underlying, often undetected, cancer.

Observation:

  • The syndrome presents with a wide range of signs and symptoms.
  • The primary cancer responsible for the coagulopathy is frequently occult, posing diagnostic challenges.

Findings:

  • Treatment approaches for Trousseau's syndrome are diverse.
  • Heparin is identified as the initial drug of choice, suitable for long-term outpatient management.
  • Warfarin has not demonstrated efficacy in treating this condition.

Implications:

Related Experiment Videos

  • Early recognition of Trousseau's syndrome is crucial for identifying occult malignancies.
  • Effective management strategies, particularly the use of heparin, can improve patient outcomes.
  • Further research may elucidate optimal treatment protocols for cancer-associated coagulopathy.